Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Conn PJ, Christopoulos A, Lindsley CW (2009) Nat Rev Drug Discov 8: 41-54 Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders. Conn PJ, Lindsley CW, Meiler J, Niswender CM (2014) Nat Rev Drug Discov 13: 692-708 RNA editing as a therapeutic target for CNS disorders. Morabito MV, Emeson RB (2009) Neuropsychopharmacology 34: 246 Neurotherapeutics. Smith GS, Li X, Conn PJ (2012) Neuropsychopharmacology 37: 1-3 Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. Haas DW, Ribaudo HJ, Kim RB, Tierney C, Wilkinson GR, Gulick RM, Clifford DB, Hulgan T, Marzolini C, Acosta EP (2004) AIDS 18: 2391-400 Development of allosteric modulators of GPCRs for treatment of CNS disorders. Nickols HH, Conn PJ (2014) Neurobiol Dis 61: 55-71 Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications. Yin S, Niswender CM (2014) Cell Signal 26: 2284-97 A combined deficiency of vitamins E and C causes severe central nervous system damage in guinea pigs. Burk RF, Christensen JM, Maguire MJ, Austin LM, Whetsell WO, May JM, Hill KE, Ebner FF (2006) J Nutr 136: 1576-81 Comparison of Roche MONITOR and Organon Teknika NucliSens assays to quantify human immunodeficiency virus type 1 RNA in cerebrospinal fluid. Spearman P, Fiscus SA, Smith RM, Shepard R, Johnson B, Nicotera J, Harris VL, Clough LA, McKinsey J, Haas DW (2001) J Clin Microbiol 39: 1612-4 Monitoring the safety of childhood immunizations: methods of linking and augmenting computerized data bases for epidemiologic studies. Griffin MR, Ray WA, Fought RL, Foster MA, Hays A, Schaffner W (1988) Am J Prev Med 4: 5-13 Classics in Chemical Neuroscience: Xanomeline. Bender AM, Jones CK, Lindsley CW (2017) ACS Chem Neurosci 8: 435-443 Neurosarcoidosis Presenting as Aseptic Meningitis in an Immunosuppressed Renal Transplant Recipient. Held EP, Iglesia EA, Johnson AS, Fang JY, Wilson MH, Abel TW, Lake W, Siew ED (2016) Transplantation 100: e96-e100 The evolution of histamine H₃ antagonists/inverse agonists. Lebois EP, Jones CK, Lindsley CW (2011) Curr Top Med Chem 11: 648-60 Nicotine and nicotinic receptor involvement in neuropsychiatric disorders. Newhouse P, Singh A, Potter A (2004) Curr Top Med Chem 4: 267-82 Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders. Gregory KJ, Noetzel MJ, Niswender CM (2013) Prog Mol Biol Transl Sci 115: 61-121 Neurologic manifestations of pediatric systemic lupus erythematosus. Steinlin MI, Blaser SI, Gilday DL, Eddy AA, Logan WJ, Laxer RM, Silverman ED (1995) Pediatr Neurol 13: 191-7 Cysticercosis: etiology and nursing care. Minnick A (1986) J Neurosci Nurs 18: 135-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.